Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2125 of 3173 entries
View as:

A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)

Phase: N/A Priority: Normal
NCT ID: NCT02766647 Org: User:
Start: 12/31/15 End: 03/31/16 Due: 03/31/17

B0151005 Open-Label Extension Study

Phase: N/A Priority: Normal
NCT ID: NCT01345318 Org: User:
Start: 06/30/11 End: 03/31/16 Due: 03/31/17

Child Pneumococcal Serotype Epidemiology In Greece

Phase: N/A Priority: Normal
NCT ID: NCT01111214 Org: User:
Start: 11/30/11 End: 11/30/12 Due: 11/30/13

A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease

Phase: N/A Priority: Normal
NCT ID: NCT05842967 Org: User:
Start: 05/11/23 End: 03/18/24 Due: 03/18/25

Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

Phase: N/A Priority: Normal
NCT ID: NCT06353087 Org: User:
Start: 07/01/24 End: 05/15/26 Due: 05/15/27

A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT03052608 Org: User:
Start: 04/27/17 End: 12/31/28 Due: 12/31/29

Fesoterodine Flexible Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT00536484 Org: User:
Start: 08/31/07 End: 03/31/08 Due: 03/31/09

A Study to Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)

Phase: N/A Priority: Normal
NCT ID: NCT05912933 Org: User:
Start: 08/19/24 End: 08/30/24 Due: 08/30/25

Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT04218084 Org: User:
Start: 11/11/20 End: 11/06/24 Due: 11/06/25

Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00560573 Org: User:
Start: 11/30/07 End: 03/31/10 Due: 03/31/11

A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05565391 Org: User:
Start: 10/03/22 End: 11/04/22 Due: 11/04/23

Bioavailability Study Of PF-00868554 Administered As 3x250mg Oral Tablets (Wet Granulate, 3x250mg Oral Tablets (Dry Granulate) And 750mg Solution Under Fed State

Phase: N/A Priority: Normal
NCT ID: NCT00861458 Org: User:
Start: 04/30/09 End: 06/30/09 Due: 06/30/10

Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids

Phase: N/A Priority: Normal
NCT ID: NCT04267250 Org: User:
Start: 08/24/20 End: 11/06/20 Due: 11/06/21

Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT01127893 Org: User:
Start: 06/15/10 End: 09/29/10 Due: 09/29/11

Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00938015 Org: User:
Start: 10/31/04 End: 04/30/12 Due: 04/30/13

A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02663518 Org: User:
Start: 01/28/16 End: 11/23/22 Due: 11/23/23

Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00457691 Org: User:
Start: 06/30/07 End: 03/31/10 Due: 03/31/11

Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009g

Phase: N/A Priority: Normal
NCT ID: NCT01480219 Org: User:
Start: 08/31/11 End: 03/31/12 Due: 03/31/13

Study Evaluating Changes In Bone Mineral Density (BMD), And Safety Of Rhbmp-2/CPM In Subjects With Decreased BMD

Phase: N/A Priority: Normal
NCT ID: NCT00752557 Org: User:
Start: 12/03/08 End: 04/24/15 Due: 04/24/16

Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00768664 Org: User:
Start: 11/04/08 End: 04/18/12 Due: 04/18/13

A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM)

Phase: N/A Priority: Normal
NCT ID: NCT02092922 Org: User:
Start: 05/31/14 End: 09/05/17 Due: 09/05/18

Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.

Phase: N/A Priority: Normal
NCT ID: NCT06086340 Org: User:
Start: 09/29/23 End: 01/24/24 Due: 01/24/25

Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT00877032 Org: User:
Start: 04/30/09 End: 07/31/11 Due: 07/31/12

Pharmacokinetics Of Orally Administered Fx-1006A In Subjects With Hepatic Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT01358565 Org: User:
Start: 11/30/10 End: 04/30/11 Due: 04/30/12

Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.

Phase: N/A Priority: Normal
NCT ID: NCT00572455 Org: User:
Start: 12/11/07 End: 06/26/09 Due: 06/26/10